Cardiovascular disease surveillance in the comparative effectiveness landscape

Circulation: Cardiovascular Quality and Outcomes

Volumn 2, Issue 5, 2009, Pages 404-406

  Roger, Véronique L ^a  

^a Division of Cardiovascular Diseases ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; COMPARATIVE EFFECTIVENESS; DRUG ELUTING STENT; EDITORIAL; ELECTRONIC MEDICAL RECORD; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEART CATHETERIZATION; INCIDENCE; LIFE EXPECTANCY; MEDICAL INFORMATION SYSTEM; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; SUSTAINABLE DEVELOPMENT; CULTURAL ANTHROPOLOGY; HEALTH SURVEY; HUMAN; NOTE;

CARDIOVASCULAR DISEASES; HUMANS; INCIDENCE; LIFE EXPECTANCY; POPULATION SURVEILLANCE; QUALITY OF HEALTH CARE; WESTERN WORLD;

EID: 77949521761     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.109.901249     Document Type: Editorial

References (17)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117: e25-e146.
2. Bishop E. Heart disease may actually be rising; researchers claim deaths are now being delayed to a later age group. Wall Street Journal. November 13, 1996, 1996;pB3(W) pB6(E) col 1 (11 col in).
3. Lewsey JD, Jhund PS, Gillies M, Chalmers JW, Redpath A, Kelso L, Briggs A, Walters M, Langhorne P, Capewell S, McMurray JJV, McIntyre K. Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circ Cardiovasc Qual Outcomes. 2009;2:475-483.
4. Roe MT, Chen AY, Cannon CP, Rao S, Rumsfeld J, Magid DJ, Brindis R, Klein LW, Gibler WB, Ohman EM, Peterson ED; on behalf of the CRUSADE and ACTION-GWTG registry participants. Temporal changes in the use of drug-eluting stents for patients with non-STsegment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) and Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (ACTION-GWTG) registries. Circ Cardiovasc Qual Outcomes. 2009;2:414-420.
5. Nestler DM, Noheria A, Haro LH, Stead LG, Decker WW, Scanlan-Hanson LN, Lennon RJ, Lim C-C, Holmes DR Jr, Rihal CS, Bell MR, Ting HH. Sustaining improvement in door-to-balloon time over 4 years: the Mayo Clinic ST-elevation myocardial infarction protocol. Circ Cardiovasc Qual Outcomes. 2009;2:508-513.
6. Gillum RF. Community surveillance for cardiovascular disease. Methods, problems, applications-a review. J Chronic Diseases. 1978;31:87-94.
7. Goff DC Jr, Brass L, Braun LT, Croft JB, Flesch JD, Fowkes FG, Hong Y, Howard V, Huston S, Jencks SF, Luepker R, Manolio T, O'Donnell C, Robertson RM, Rosamond W, Rumsfeld J, Sidney S, Zheng ZJ. Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease. Circulation. 2007;115:127-155. (Pubitemid 46058620)
8. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease. N Engl J Med. 1998;339:861-867.
9. McGovern PG, Jacobs DR Jr, Shahar E, Arnett DK, Folsom AR, Blackburn H, Luepker RV. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation. 2001;104:19-24.
10. Roger VL, Killian J, Henkel M, Weston SA, Goraya TY, Yawn BP, Kottke TE, Frye RL, Jacobsen SJ. Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol. 2002; 55:593-601.
11. Goldberg RJ, Gorak EJ, Yarzebski J, Hosmer DW Jr, Dalen P, Gore JM, Alpert JS, Dalen JE. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation. 1993;87:1947-1953.
12. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2000.
13. Zerhouni E. Medicine. The NIH Roadmap. Science. 2003;302(5642): 63-72.
14. Sox HC, Greenfield S. Comparative effectiveness research: a report from the institute of medicine. Ann Intern Med. 2009;151:203-205.
15. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med. 2009;151:206-209.
16. Lauer MS. Comparative effectiveness research: the view from the NHLBI. J Am Coll Cardiol. 2009;53:1084-1086.
17. Gibbons RJ, Gardner TJ, Anderson JL, Goldstein LB, Meltzer N, Weintraub WS, Yancy CW. The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association. Circulation. 2009;119:2955-2962.